The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of removing an oncologist-directed behavioral nudge on sustaining rates of serious illness conversations: An interrupted time series analysis.
 
Ryan M O'Keefe
No Relationships to Disclose
 
E. Paul Wileyto
No Relationships to Disclose
 
Peter Edward Gabriel
No Relationships to Disclose
 
Daniel Blumenthal
No Relationships to Disclose
 
Sharon Tejada
No Relationships to Disclose
 
Rinad S Beidas
Honoraria - Optum/UnitedHealth Group
Consulting or Advisory Role - Optum/UnitedHealth Group; OptumLabs
 
Robert Schnoll
No Relationships to Disclose
 
Justin E. Bekelman
Stock and Other Ownership Interests - Reimagine Care
Honoraria - National Comprehensive Cancer Network
Consulting or Advisory Role - AstraZeneca; Healthcare Foundry; Reimagine Care; UnitedHealthcare
Research Funding - Gilead Sciences (Inst); Loxo@Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Patent Pending: Machine Learning Systems Using Electronic Health Record Data and Patient-Reported Outcomes; 17/972,105
 
Ravi Bharat Parikh
Stock and Other Ownership Interests - GNS Healthcare; Google; Merck; Onc.AI; Thyme Care
Consulting or Advisory Role - Biofourmis; G1 Therapeutics; Genetic Chemistry Therapeutics; Humana; Merck; NanOlogy; Thyme Care
Research Funding - Humana
Patents, Royalties, Other Intellectual Property - Technology to integrate patient-reported outcomes into electronic health record algorithms
Travel, Accommodations, Expenses - The Oncology Institute of Hope and Innovation
 
Samuel U Takvorian
Stock and Other Ownership Interests - Bluebird Bio (I); Gilead Sciences (I); Johnson & Johnson (I); Merck (I); Novartis (I); Pfizer (I); Pfizer (I); Portola Pharmaceuticals (I)
Consulting or Advisory Role - AstraZeneca/Merck; Boehringer Ingelheim (I); Genentech; Health Advances; Novartis (I); Novocure (I)
Research Funding - AstraZeneca (I); Lilly (I); Pfizer; Trizell (I)